Cardio Diagnostics Holdings Stock Market Value
| CDIOW Stock | USD 0.02 0 17.26% |
| Symbol | Cardio |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cardio Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cardio Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cardio Diagnostics.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Cardio Diagnostics on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Cardio Diagnostics Holdings or generate 0.0% return on investment in Cardio Diagnostics over 90 days. Cardio Diagnostics is related to or competes with Biocardia, Acurx Pharmaceuticals, Aptevo Therapeutics, Aprea Therapeutics, Kiora Pharmaceuticals, Tevogen Bio, and In8bio. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of ca... More
Cardio Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cardio Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cardio Diagnostics Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.75 | |||
| Information Ratio | 0.0349 | |||
| Maximum Drawdown | 48.43 | |||
| Value At Risk | (18.12) | |||
| Potential Upside | 17.22 |
Cardio Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardio Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cardio Diagnostics' standard deviation. In reality, there are many statistical measures that can use Cardio Diagnostics historical prices to predict the future Cardio Diagnostics' volatility.| Risk Adjusted Performance | 0.0408 | |||
| Jensen Alpha | 0.4157 | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | 0.038 | |||
| Treynor Ratio | (1.82) |
Cardio Diagnostics January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0408 | |||
| Market Risk Adjusted Performance | (1.81) | |||
| Mean Deviation | 6.56 | |||
| Semi Deviation | 8.14 | |||
| Downside Deviation | 8.75 | |||
| Coefficient Of Variation | 2321.91 | |||
| Standard Deviation | 9.53 | |||
| Variance | 90.91 | |||
| Information Ratio | 0.0349 | |||
| Jensen Alpha | 0.4157 | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | 0.038 | |||
| Treynor Ratio | (1.82) | |||
| Maximum Drawdown | 48.43 | |||
| Value At Risk | (18.12) | |||
| Potential Upside | 17.22 | |||
| Downside Variance | 76.52 | |||
| Semi Variance | 66.29 | |||
| Expected Short fall | (8.73) | |||
| Skewness | 0.1596 | |||
| Kurtosis | 1.28 |
Cardio Diagnostics Backtested Returns
At this stage we consider Cardio Stock to be out of control. Cardio Diagnostics secures Sharpe Ratio (or Efficiency) of 0.0177, which signifies that the company had a 0.0177 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Cardio Diagnostics Holdings, which you can use to evaluate the volatility of the firm. Please confirm Cardio Diagnostics' Mean Deviation of 6.56, downside deviation of 8.75, and Risk Adjusted Performance of 0.0408 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%. Cardio Diagnostics has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.22, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cardio Diagnostics are expected to decrease at a much lower rate. During the bear market, Cardio Diagnostics is likely to outperform the market. Cardio Diagnostics right now shows a risk of 10.01%. Please confirm Cardio Diagnostics value at risk, as well as the relationship between the kurtosis and market facilitation index , to decide if Cardio Diagnostics will be following its price patterns.
Auto-correlation | -0.7 |
Very good reverse predictability
Cardio Diagnostics Holdings has very good reverse predictability. Overlapping area represents the amount of predictability between Cardio Diagnostics time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cardio Diagnostics price movement. The serial correlation of -0.7 indicates that around 70.0% of current Cardio Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.